2 unknown, 1 not yet recruiting. 2 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Fengmei Lian: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus 1/bag of Jinlida granules, 3 times/day, taken with hot water. - Obese Impaired Glucose Tolerance, Newly Diagnosed Obese Type 2 Diabetic Patients | Phase 2 | Not yet recruiting | Fengmei Lian | 380 | 2024-07-01 | 2024-07-11 |
| Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy Mudan granule, Placebo - Diabetic Peripheral Neuropathy Type 2 | Early Phase 1 | Unknown | Fengmei Lian | 402 | 2021-06-01 | 2021-01-15 |
| Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy Tangwang prescription, Placebo - Diabetic Non-proliferative Retinopathy, Type2 Diabetes | Early Phase 1 | Unknown | Fengmei Lian | 384 | 2017-02-01 | 2017-01-20 |
China (1)
Chun Li Piao, Ph.D. (1) · Jing Liu, Ph.D. (1) · Ping Liu, Master (1) · Qiu Chen, Ph.D. (1) · Yi Li, Ph.D. (1)